Suppr超能文献

影像学在评估胃癌淋巴结状态中的应用

Imaging in assessing lymph node status in gastric cancer.

作者信息

Kwee Robert Michael, Kwee Thomas Christian

机构信息

Department of Radiology, Maastricht University Medical Center, P. Debyelaan 25, 6202 AZ, Maastricht, The Netherlands.

出版信息

Gastric Cancer. 2009;12(1):6-22. doi: 10.1007/s10120-008-0492-5. Epub 2009 Apr 24.

Abstract

BACKGROUND

Accurate assessment of lymph node status is of crucial importance for appropriate treatment planning and determining prognosis in patients with gastric cancer. The aim of this study was to systematically review the current role of imaging in assessing lymph node (LN) status in gastric cancer.

METHODS

A systematic literature search was performed in the PubMed/MEDLINE and Embase databases. The methodological quality and diagnostic performance of the included studies was assessed.

RESULTS

Six abdominal ultrasonography (AUS) studies, 30 endoscopic ultrasonography (EUS) studies, 10 multidetectorrow computed tomography (MDCT) studies, 3 conventional magnetic resonance imaging (MRI) studies, 4 (18)F-fluoro-2-deoxyglucose positron emission tomography (FDG-PET) studies, and 1 FDG-PET/CT fusion study were included. In general, the included studies had moderate methodological quality. The sensitivity and specificity of AUS varied between 12.2% and 80.0% (median, 39.9%) and 56.3% and 100% (median, 81.8%). The sensitivity and specificity of EUS varied between 16.7% and 95.3% (median, 70.8%) and 48.4% and 100% (median, 84.6%). The sensitivity and specificity of MDCT varied between 62.5% and 91.9% (median, 80.0%) and 50.0% and 87.9% (median, 77.8%). The sensitivity and specificity of MRI varied between 54.6% and 85.3% (median, 68.8%) and 50.0% and 100% (median, 75.0%). The sensitivity and specificity of FDG-PET varied between 33.3% and 64.6% (median, 34.3%) and 85.7% and 97.0% (median, 93.2%). The sensitivity and specificity of the FDG-PET/CT fusion study were 54.7% and 92.2%. For all the imaging modalities, there were no significant differences between the mean sensitivities and specificities of high- and low-quality studies.

CONCLUSION

AUS, EUS, MDCT, conventional MRI, and FDG-PET cannot reliably be used to confirm or exclude the presence of LN metastasis. The performance of highresolution PET/CT fusion and functional MRI techniques still has to be determined.

摘要

背景

准确评估淋巴结状态对于胃癌患者的恰当治疗规划及判断预后至关重要。本研究的目的是系统评价影像学在评估胃癌淋巴结(LN)状态中的当前作用。

方法

在PubMed/MEDLINE和Embase数据库中进行了系统的文献检索。对纳入研究的方法学质量和诊断性能进行了评估。

结果

纳入了6项腹部超声(AUS)研究、30项内镜超声(EUS)研究、10项多排螺旋计算机断层扫描(MDCT)研究、3项传统磁共振成像(MRI)研究、4项氟代脱氧葡萄糖正电子发射断层显像(FDG-PET)研究以及1项FDG-PET/CT融合研究。总体而言,纳入研究的方法学质量中等。AUS的敏感性在12.2%至80.0%(中位数,39.9%)之间,特异性在56.3%至100%(中位数,81.8%)之间。EUS的敏感性在16.7%至95.3%(中位数,70.8%)之间,特异性在48.4%至100%(中位数,84.6%)之间。MDCT的敏感性在62.5%至91.9%(中位数,80.0%)之间,特异性在50.0%至87.9%(中位数,77.8%)之间。MRI的敏感性在54.6%至85.3%(中位数,68.8%)之间,特异性在50.0%至100%(中位数,75.0%)之间。FDG-PET的敏感性在33.3%至64.6%(中位数,34.3%)之间,特异性在85.7%至97.0%(中位数,93.2%)之间。FDG-PET/CT融合研究的敏感性和特异性分别为54.7%和92.2%。对于所有成像模态,高质量和低质量研究的平均敏感性和特异性之间均无显著差异。

结论

AUS、EUS、MDCT、传统MRI和FDG-PET不能可靠地用于证实或排除LN转移。高分辨率PET/CT融合和功能MRI技术的性能仍有待确定。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验